Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study

The STRIDE Weight Loss and Lifestyle Intervention for Individuals Taking Antipsychotic Medications: A Randomized Trial

(2015) Carla A. Green et al.   AMERICAN JOURNAL OF PSYCHIATRY

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

(2015) Christoph U. Correll et al.   World Psychiatry

Weight gain and antipsychotics: a drug safety review

(2014) Richard Musil et al.   Expert Opinion On Drug Safety

Cause and Rate of Death in People With Schizophrenia Across the Lifespan

(2014) Maia S. Kredentser et al.   JOURNAL OF CLINICAL PSYCHIATRY

“First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects

(2014) Su Ling Young et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder

(2013) L. Fredrik Jarskog et al.   AMERICAN JOURNAL OF PSYCHIATRY

Metformin for Treatment of Antipsychotic-Induced Amenorrhea and Weight Gain in Women With First-Episode Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study

(2012) Ren-Rong Wu et al.   AMERICAN JOURNAL OF PSYCHIATRY

Weight Change From 3-Year Observational Data

(2012) Chris J. Bushe et al.   JOURNAL OF CLINICAL PSYCHIATRY

A systematic review of correlates of physical activity in patients with schizophrenia

(2011) D. Vancampfort et al.   ACTA PSYCHIATRICA SCANDINAVICA

Dose Response Between Physical Activity and Risk of Coronary Heart Disease

(2011) Jacob Sattelmair et al.   CIRCULATION

Efficacy of metformin for prevention of weight gain in psychiatric populations

(2011) Hannah Newall et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Analysis of Metformin Treatment for Adolescent Obesity at 48 Rather Than 24 Weeks After Treatment Cessation—Reply

(2010) Darrell M. Wilson   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis

(2010) Samir Kumar Praharaj et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Intentional Weight Loss in Overweight and Obese Patients With Severe Mental Illness

(2010) Richard I. G. Holt et al.   JOURNAL OF CLINICAL PSYCHIATRY

Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs

(2010) Mehrul Hasnain et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis

(2010) Linda Björkhem-Bergman et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study

(2009) Edgardo Carrizo et al.   SCHIZOPHRENIA RESEARCH

Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study

(2008) Ren-Rong Wu et al.   AMERICAN JOURNAL OF PSYCHIATRY

Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials

(2008) Mario Álvarez-Jiménez et al.   BRITISH JOURNAL OF PSYCHIATRY

Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain

(2008) Ren-Rong Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study

(2008) Trino Baptista et al.   PSYCHIATRY RESEARCH